IMPACT OF CFTR MODULATOR THERAPY (LEXACAFTOR/TEZACAFTOR/IVACAFTOR) ON PSEUDOMONAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS

被引：0
|
作者：
Sheikh, Shahid I.
Britt, Rodney D.
Ryan-Wenger, Nancy A.
Khan, Aiman Q.
Gushue, Courtney A.
McCoy, Karen S.
Kopp, Benjamin
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1278
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1519A / 1520A
页数：2
相关论文
共 50 条
  • [21] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [22] Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
    Casey, Michelle
    Gabillard-Lefort, Claudie
    McElvaney, Oisin F.
    McElvaney, Oliver J.
    Carroll, Tomas
    Heeney, Ronan C.
    Gunaratnam, Cedric
    Reeves, Emer P.
    Murphy, Mark P.
    McElvaney, Noel G.
    THORAX, 2023, 78 (08) : 835 - 839
  • [23] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [24] Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
    De Vuyst, Richard C.
    Bennard, Erin
    Kam, Charissa W.
    McKinzie, Cameron J.
    Esther, Charles R.
    PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1592 - 1594
  • [25] Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy
    Beswick, Daniel M.
    Humphries, Stephen M.
    Balkissoon, Connor D.
    Strand, Matthew
    Vladar, Eszter K.
    Ramakrishnan, Vijay R.
    Taylor-Cousar, Jennifer L.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : E141 - E147
  • [26] Effect of elexacaftor-tezacaftor- ivacaftor modulator on lung structure in cystic fibrosis
    Fainardi, V.
    Skenderaj, K.
    Ciuni, A.
    Esposito, S.
    Sverzellati, N.
    Pisi, G.
    PULMONOLOGY, 2023, 29 (05): : 441 - 443
  • [27] IMPACT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR ELEXACAFTOR-TEZACAFTOR-IVACAFTOR ON LUNG FUNCTION, BMI, BACTERIAL COLONIZATION, AND ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH CYSTIC FIBROSIS
    Sheikh, Shahid
    Britt, Rodney
    Khan, Aiman
    Ryan-Wenger, Nancy
    Johnson, Terri
    McCoy, Karen
    Kopp, Benjamin
    CHEST, 2021, 160 (04) : 1446A - 1447A
  • [28] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [29] The impact of elexacaftor/tezacaftor/ivacaftor on adherence to maintenance therapies in cystic fibrosis
    Johnson, Ellie
    Land, Rachel
    Reid, David
    RESPIROLOGY, 2024, 29 : 7 - 7
  • [30] Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy
    Southern, Kevin W.
    Barben, Jurg
    Goldring, Stephen
    Kneen, Rachel
    Southward, Suzanne
    Rajeev, Yashasvi
    Davies, Jane C.
    Bush, Andrew
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 103 - 105
12345